MaxCyte MXCT 深 沪
等待开盘 07-18 09:30:00 美东时间
2.15
+0.030
+1.42%
华盛通- 最 高2.19
- 今 开2.14
- 成交量 43.71万股
- 最 低 2.11
- 昨 收 2.12
- 总市值 2.28亿
- 52周最高 5.20
- 市盈率 静 --
- 换手率 0.41%
- 52周最低 2.00
- 委 比 51.53%
- 总股本 1.06亿
- 历史最高 17.44
- 量 比 0.85
- 振 幅 3.77%
- 历史最低 2.00
- 每 手 1
- 风险率 0.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025
MaxCyte, Inc. announced it will release its second-quarter 2025 financial results after the U.S. market close on August 6, 2025. Management will host a conference call at 4:30 p.m. ET to discuss the results. Investors must register online in advance, and a live or archived webcast will be available on the company's website. MaxCyte, a leader in cell-engineering technologies, provides innovative solutions for next-generation cell therapies.
07-09 12:05
MaxCyte Cancels AIM Market Trading for Common Stock
MaxCyte ( ($MXCT) ) just unveiled an announcement. On June 25, 2025, MaxCyte, I...
06-26 05:00
MaxCyte Shareholders Approve Equity Plan Amendment
An update from MaxCyte ( ($MXCT) ) is now available. At the 2025 annual meeting...
06-19 05:18
MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies
MaxCyte and Ori Biotech collaborate to integrate their ExPERT™ and IRO® platforms, aiming to enhance gene-edited T cell yields and shorten manufacturing timelines. Combining MaxCyte's Flow Electroporation® technology with Ori's IRO® platform, the partnership focuses on optimizing T cell production through automated processes. The collaboration uses CD19 CAR expression in activated T cells as a test system, targeting faster, more efficient cell th...
06-11 06:00
MaxCyte Expands Stock Capital Amidst Strategic Growth
The latest announcement is out from MaxCyte ( ($MXCT) ). MaxCyte, Inc. announce...
06-03 00:17
BlackRock Increases Stake in MaxCyte
MaxCyte ( ($MXCT) ) just unveiled an announcement. MaxCyte, Inc., a non-UK issu...
06-02 23:22
BlackRock Increases Stake in MaxCyte to 7.65%
The latest announcement is out from MaxCyte ( ($MXCT) ). MaxCyte, Inc., a non-U...
05-20 01:07
Earnings Outlook For Quanterix
Quanterix (NASDAQ:QTRX) will release its quarterly earnings report on Monday, 2...
05-10 05:02
MaxCyte Affirms FY2025 Sales Guidance of $35.11M-$37.39M vs $41.30M Est
MaxCyte (NASDAQ:MXCT) affirms FY2025 sales outlook from $35.11 million-$37.39 million to $35.11 million-$37.39 million vs $41.30 million estimate.
05-08 04:28
